ELAVL1 and acute myeloid leukemia: Furthermore, in acute myeloid leukemia, miR-29b reduces the levels of human antigen R (HuR, also known as ELAVL1 for embryonic lethal abnormal vision 1) by targeting its transcript [52], resulting in decreased levels of RELA (v-rel avian reticuloendotheliosis viral oncogene homolog A, also known as p65 or NFKB3) in the cell nucleus and reduced phosphorylation levels of RELA, IκBα, STAT1, STAT3, and STAT5.